United Healthcare Stock Price: An In-Depth Analysis for Serious Investors
The united healthcare stock price has been one of the most discussed numbers in healthcare investing, and for good reason. UnitedHealth Group (UNH) is not just a large company; it is the largest private health insurer in the United States by revenue and the heaviest-weighted constituent in the Dow Jones Industrial Average because of its share price structure. That price-weight quirk means UNH moves the Dow more than companies with three times the market capitalization. Understanding the stock requires separating what the price tag signals from what the underlying business actually earns.
As of April 2026, UNH trades above $540 per share. The trailing P/E sits near 20.1, the forward P/E near 16.8, and the five-year revenue CAGR comes in around 11.4%. Those numbers place UNH in an interesting position for value-focused investors: not cheap, but not frothy by healthcare sector standards either.
Key Takeaways
- The united healthcare stock price above $540 gives it roughly 10.9% weight in the Dow Jones Industrial Average, far exceeding its market-cap share.
- UNH's ROIC has averaged above 18% over the past five years, well above the healthcare sector median of around 11%.
- The company generated over $22 billion in operating cash flow in fiscal 2025, making it one of the most cash-productive businesses in any sector.
- Debt-to-equity stands near 0.72, moderate for a company of this scale and consistent with investment-grade credit ratings.
- The Piotroski F-Score for UNH typically registers 7 or 8 out of 9, signaling strong financial health across profitability, use, and efficiency dimensions.
- Medicare Advantage enrollment growth and Optum's data and analytics business are the two growth vectors most analysts watch most closely.
What the United Healthcare Stock Price Actually Represents
Headline price tells you almost nothing about value. A stock trading at $540 is not expensive because of the number; it is expensive or cheap based on what $540 buys you in earnings, cash flow, and future growth. UNH's revenue base exceeded $400 billion in fiscal 2025, placing it among the ten largest revenue-generating companies in the world.
The share price climbed from roughly $150 in 2017 to its current level on the back of consistent earnings growth, Optum's scale expansion, and a structural shift toward value-based care arrangements that tend to reward managed care organizations over fee-for-service providers. That trajectory is not an accident; it reflects a business model built around predictable premium revenue, disciplined medical cost management, and a growing data infrastructure that competitors cannot easily replicate.
UNH Fundamentals at a Glance
Running UNH through our screener against healthcare sector peers gives you this picture as of April 2026:
| Metric | UNH | Healthcare Sector Median | S&P 500 Median |
|---|---|---|---|
| Trailing P/E | 20.1 | 22.4 | 23.1 |
| Forward P/E | 16.8 | 18.3 | 19.6 |
| Price-to-Book | 5.6 | 3.1 | 4.2 |
| ROIC | 18.3% | 11.0% | 13.4% |
| Debt-to-Equity | 0.72 | 0.88 | 0.71 |
| Operating Cash Flow Margin | 5.4% | 4.1% | 8.2% |
| Dividend Yield | 1.6% | 1.8% | 1.4% |
| 5-Year Revenue CAGR | 11.4% | 6.2% | 7.1% |
The price-to-book of 5.6 looks elevated, but this is a known artifact of UNH's acquisition-heavy growth strategy, which loads the balance sheet with goodwill and intangibles rather than hard assets. Strip those out and the returns on tangible equity run considerably higher.
The Two Business Segments That Drive the Stock
UnitedHealth Group operates through two primary divisions: UnitedHealthcare (the insurance business) and Optum (the health services and data platform). Most coverage focuses on the insurance premiums and medical loss ratios. The more interesting growth story sits inside Optum.
Optum Health serves as a care delivery organization managing value-based care arrangements for millions of patients. Optum Rx is one of the three dominant pharmacy benefit managers in the U.S. Optum Insight provides data analytics, claims processing, and revenue cycle management to hospitals and health systems. Together, Optum generated over $100 billion in revenue in fiscal 2025 and operates at meaningfully higher margins than the insurance segment.
The key investment thesis is that these two segments reinforce each other. UnitedHealthcare feeds claims data into Optum Insight. Optum Health takes on clinical risk that UnitedHealthcare underwrites. The vertical integration creates switching costs and margin expansion opportunities that a standalone insurer cannot achieve.
How the Medical Loss Ratio Affects the Stock Price
The medical loss ratio (MLR) is the percentage of premium revenue paid out in medical claims. For a managed care company, this number is the single most watched operating metric quarter to quarter. UNH targets an MLR in the 82-84% range. When it trends toward 85% or above, operating income contracts fast and the united healthcare stock price typically follows.
In 2024 and early 2025, elevated post-pandemic care utilization pushed MLRs above targets across the managed care sector. UNH was not immune. The stock pulled back from prior highs as the market repriced the near-term earnings impact. That correction created a valuation window that several value-focused managers used to add to positions at forward P/Es below 15.
The lesson is consistent with what we see across our screener database: healthcare insurer stocks tend to overshoot on the downside when MLR surprises are negative, because the market extrapolates a temporary claims spike into a permanent margin impairment. Investors who model through the cycle rather than anchoring on the current quarter tend to find better entry points.
ROIC Consistency and the Quality Argument
One of the most important filters in our VMCI Score is ROIC consistency, which sits inside the Quality pillar (30% of total score). UNH has posted ROIC above 15% in each of the past seven fiscal years. That kind of consistency matters because it signals pricing power, cost discipline, and a durable competitive position.
Compare that to a lower-quality insurer cycling between 8% and 18% ROIC depending on the claims cycle. The variance alone tells you the business model is structurally weaker even when the peak numbers look attractive. Consistent ROIC above the cost of capital, year after year, is how intrinsic value compounds.
At the VMCI level, UNH typically scores well on Value (forward P/E below sector), very well on Quality (ROIC, operating margins, cash conversion), and adequately on Integrity (clean financials, low accrual ratios). The Growth and Risk pillars introduce some nuance: Medicare Advantage reimbursement rate risk from CMS is a real and recurring headwind that any honest analysis has to include.
Risks That Serious Investors Should Model
Four risks deserve explicit attention before any position in UNH.
Medicare Advantage reimbursement. CMS sets Medicare Advantage benchmark rates annually. A negative rate adjustment compresses margins directly. The 2024 rate announcement was below industry expectations and was one of the main catalysts for the 2024-2025 pullback.
Regulatory and political risk. Federal price transparency rules, pharmacy benefit manager reform legislation, and periodic antitrust scrutiny around vertical integration all create event risk. None has proven fatal to the business model so far, but the regulatory environment is more active than it was a decade ago.
Medical cost inflation. Labor costs in healthcare have risen faster than general CPI since 2020. When specialty drug utilization spikes or a new high-cost therapy achieves broad coverage, UNH absorbs the initial impact before premiums adjust.
Execution risk inside Optum. The Optum acquisitions depend on successful integration of data systems, clinical practices, and technology platforms. Integration failures or goodwill impairments would weigh on book value and potentially on future ROIC.
None of these risks makes UNH uninvestable. They do make it a stock where position sizing and entry price matter more than the buy-and-forget framing that some analysts apply to large-cap healthcare.
How the United Healthcare Stock Price Fits in a Value Portfolio
At a forward P/E near 16.8 and a five-year earnings growth rate estimate near 12%, UNH offers a PEG ratio below 1.5. By that measure it screens as reasonably valued relative to its growth trajectory. Compare that to Johnson & Johnson (JNJ) at a P/E near 15.4 with slower expected growth and a yield of 3.1%, or to Humana and CVS Health, which trade at lower multiples but carry structurally weaker ROIC profiles.
The right comparison is not "is UNH cheap on an absolute basis" but "does UNH offer better risk-adjusted compounding than the alternatives at this price." Our DCF calculator lets you stress-test that question with your own assumptions about MLR normalization, Optum margin expansion, and long-term earnings growth.
For investors who already hold healthcare exposure through a diversified ETF, adding UNH as a single-name position means taking on company-specific regulatory and MLR risk in exchange for the quality premium embedded in its ROIC history. That trade can make sense at the right price. It rarely makes sense when the market is pricing in perfection.
Further reading: Investopedia · CFA Institute
Why UNH stock analysis Matters
This section anchors the discussion on UNH stock analysis. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply UNH stock analysis in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for UNH stock analysis
See the main discussion of UNH stock analysis in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using UNH stock analysis alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for UNH stock analysis
See the main discussion of UNH stock analysis in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using UNH stock analysis alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- ROIC Consistency — ROIC Consistency measures how efficiently a company converts capital into earnings
- Debt To Equity — Glossary entry for Debt To Equity
- Piotroski F-Score — Piotroski F-Score captures the reliability of reported earnings versus underlying cash flow
- Dow Jones — related ValueMarkers analysis
- Nasdaq Nvda Financials — related ValueMarkers analysis
- Dcf Stock Valuation Calculator — related ValueMarkers analysis
Frequently Asked Questions
what happens if the stock market crashes
A stock market crash typically compresses P/E multiples across all sectors, including healthcare. UNH tends to be less volatile than the broader market in sharp corrections because healthcare demand is relatively inelastic, people still need medical coverage regardless of economic conditions. In the 2020 COVID crash, UNH fell roughly 28% from peak to trough before recovering, compared to the S&P 500's 34% drawdown. That relative resilience is one reason defensive investors include managed care in portfolios designed for downside protection.
what time does the stock market open
U.S. stock markets open at 9:30 a.m. Eastern Time on weekdays, excluding federal holidays. Pre-market trading on most platforms starts at 4:00 a.m. Eastern, and after-hours trading runs until 8:00 p.m. Eastern. UNH earnings releases often land before market open, so the pre-market session can show significant price movement before the regular session begins.
are stock markets closed today
U.S. stock markets close on federal holidays including New Year's Day, Martin Luther King Jr. Day, Presidents' Day, Good Friday, Memorial Day, Juneteenth, Independence Day, Labor Day, Thanksgiving, and Christmas. The NYSE and Nasdaq publish their official holiday schedules annually. On early close days (typically the day before Thanksgiving and Christmas Eve), markets close at 1:00 p.m. Eastern.
what time does the stock market close
The New York Stock Exchange and Nasdaq both close at 4:00 p.m. Eastern Time on regular trading days. After-hours electronic trading continues until 8:00 p.m. Eastern. Significant news events like UNH earnings reports released after 4:00 p.m. are priced into the after-hours session and typically reflected in the next morning's open, though pre-market trading begins at 4:00 a.m. Eastern.
when does the stock market open
The stock market opens at 9:30 a.m. Eastern Time, Monday through Friday, on days that are not federal holidays. Extended-hours trading is available from 4:00 a.m. through 8:00 p.m. Eastern on most online brokerage platforms. Volume in extended hours is significantly lower than in the regular session, which can lead to wider bid-ask spreads on stocks like UNH, particularly around earnings dates.
why is the stock market down today
Day-to-day market declines usually reflect a mix of factors: macroeconomic data releases, Federal Reserve commentary on interest rates, geopolitical events, or sector-specific news. For UNH specifically, earnings misses driven by elevated medical cost ratios, adverse CMS reimbursement announcements, or regulatory actions against pharmacy benefit managers have historically been the triggers for sharp single-day declines in the united healthcare stock price. Broader market sell-offs typically move UNH less than the index because of its defensive revenue characteristics.
Start analyzing UNH and other healthcare stocks with the same indicators professional investors use. Run them through our screener with 120+ fundamental indicators across quality, value, and growth dimensions.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.